Nurix Therapeutics
NRIX
NRIX
123 hedge funds and large institutions have $377M invested in Nurix Therapeutics in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.65% less ownership
Funds ownership: 90.52% → 89.86% (-0.65%)
19% less capital invested
Capital invested by funds: $462M → $377M (-$85.6M)
Holders
123
Holding in Top 10
–
Calls
$2.15M
Puts
$19K
Top Buyers
| 1 | +$6.49M | |
| 2 | +$5.64M | |
| 3 | +$3.74M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$2.23M |
| 5 |
BlackRock
New York
|
+$1.32M |
Top Sellers
| 1 | -$5.94M | |
| 2 | -$4.91M | |
| 3 | -$4.75M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.42M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$2.23M |